| Style | Citing Format |
|---|---|
| MLA | Ahmadi M, Keshavarz SA, Abbasi B. "Effects of Alpha Lipoic Acid Supplementation on Serum Lipid Profile in Patients With Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial." ARYA Atherosclerosis, vol. 18, no. August, 2022, pp. -. |
| APA | Ahmadi M, Keshavarz SA, Abbasi B (2022). Effects of Alpha Lipoic Acid Supplementation on Serum Lipid Profile in Patients With Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. ARYA Atherosclerosis, 18(August), -. |
| Chicago | Ahmadi M, Keshavarz SA, Abbasi B. "Effects of Alpha Lipoic Acid Supplementation on Serum Lipid Profile in Patients With Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial." ARYA Atherosclerosis 18, no. August (2022): -. |
| Harvard | Ahmadi M, Keshavarz SA, Abbasi B (2022) 'Effects of Alpha Lipoic Acid Supplementation on Serum Lipid Profile in Patients With Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial', ARYA Atherosclerosis, 18(August), pp. -. |
| Vancouver | Ahmadi M, Keshavarz SA, Abbasi B. Effects of Alpha Lipoic Acid Supplementation on Serum Lipid Profile in Patients With Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. ARYA Atherosclerosis. 2022;18(August):-. |
| BibTex | @article{ author = {Ahmadi M and Keshavarz SA and Abbasi B}, title = {Effects of Alpha Lipoic Acid Supplementation on Serum Lipid Profile in Patients With Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial}, journal = {ARYA Atherosclerosis}, volume = {18}, number = {August}, pages = {-}, year = {2022} } |
| RIS | TY - JOUR AU - Ahmadi M AU - Keshavarz SA AU - Abbasi B TI - Effects of Alpha Lipoic Acid Supplementation on Serum Lipid Profile in Patients With Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial JO - ARYA Atherosclerosis VL - 18 IS - August SP - EP - PY - 2022 ER - |